Study guide
8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia
Veterinary Technician Specialist in Emergency and Critical Care VTS ECC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Triage & Point-of-Care Assessment
1.1 AVECCTN Examination Structure, Blueprint & Credentialing 1.2 Emergency Triage Systems, Primary Survey & Capsule Diagnostics 1.3 Point-of-Care Ultrasound (POCUS / TFAST / AFAST / VetBLUE) & Rapid Interventions
2 Chapter 2: Cardiovascular Emergencies & RECOVER CPR
2.1 RECOVER Guidelines: Basic Life Support (BLS) & Resuscitation Dynamics 2.2 Advanced Life Support (ALS): Emergency Pharmacopeia, Reversals & Defibrillation 2.3 Electrocardiogram (ECG) Interpretation & Antiarrhythmic Therapy 2.4 Congestive Heart Failure, Cardiac Tamponade & Feline Aortic Thromboembolism
3 Chapter 3: Fluid Therapy, Shock Resuscitation & Acid-Base Balance
3.1 Pathophysiology, Stages & Classification of Shock 3.2 Fluid Dynamics, Crystalloids, Colloids & Hypertonic Resuscitation 3.3 Electrolyte Disorders: Potassium, Sodium, Calcium & Phosphorus 3.4 Arterial & Venous Blood Gas Analysis & Acid-Base Disorders
4 Chapter 4: Respiratory Emergencies & Mechanical Ventilation
4.1 Upper Airway Obstruction: BOAS, Laryngeal Paralysis & Tracheal Collapse 4.2 Lower Airway, Pulmonary Parenchymal & Vascular Emergencies: Asthma, Contusions & ARDS 4.3 Pleural Space Disease, Emergency Thoracocentesis & Chest Tube Management 4.4 Oxygen Delivery Modalities, Capnography & Mechanical Ventilation Basics
5 Chapter 5: Gastrointestinal & Hepatic Emergencies
5.1 Gastric Dilatation-Volvulus (GDV): Resuscitation, Decompression & Critical Nursing 5.2 Acute Abdomen, Septic Peritonitis & Canine Parvoviral Enteritis 5.3 Acute Pancreatitis, Acute Hemorrhagic Diarrhea Syndrome & Mesenteric Volvulus 5.4 Acute Hepatic Failure, Hepatic Encephalopathy & Biliary Emergencies
6 Chapter 6: Anesthesia, Analgesia & Constant Rate Infusions
6.1 Emergency Anesthesia Protocols & High-Risk Patient Stabilization 6.2 Multimodal Analgesia, Pain Scoring Scales & Local/Regional Anesthesia 6.3 Constant Rate Infusions (CRIs): Formulations, Calculations & Monitoring 6.4 Anesthetic Complications: Hypotension, Hypothermia & Emergency Interventions
7 Chapter 7: Renal & Urinary Emergencies
7.1 Acute Kidney Injury (AKI): Pathophysiology, IRIS Staging & Renal Replacement Therapy 7.2 Feline Urethral Obstruction: Deobstruction, Electrolyte Crises & Post-Obstructive Diuresis 7.3 Uroabdomen & Lower Urinary Tract Trauma: Diagnosis & Resuscitation
8 Chapter 8: Hemolymphatic, Transfusion Medicine & Sepsis/SIRS
8.1 Transfusion Medicine: Blood Typing, Crossmatching & Component Therapy 8.2 Immune-Mediated Hemolytic Anemia (IMHA) & Immune-Mediated Thrombocytopenia (IMTP) 8.3 Sepsis, Systemic Inflammatory Response Syndrome (SIRS) & DIC 8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia
9 Chapter 9: Environmental, Toxicological, Ophthalmic & Exotic Species Emergencies
9.1 Heatstroke, Severe Hypothermia & Thermal Burn Management 9.2 Envenomation Syndromes & Acute Anaphylaxis Management 9.3 Common Small Animal Toxicities: Chocolate, Xylitol, NSAIDs & Rodenticides 9.4 Neurotoxins, Ethylene Glycol, Plant Toxins & Extracorporeal Therapies 9.5 Ophthalmologic Emergencies: Proptosis, Acute Glaucoma, Corneal Perforation & Chemical Injury 9.6 Emergency Care of Exotic Companion Species: Rabbits, Rodents, Ferrets, Birds & Reptiles
10 Chapter 10: Neurological Emergencies
10.1 Status Epilepticus & Cluster Seizures: Emergency Protocols & Refractory Therapy 10.2 Traumatic Brain Injury (TBI), Intracranial Pressure (ICP) & Modified Glasgow Coma Scale 10.3 Acute Spinal Cord Emergencies: Intervertebral Disc Disease (IVDD) & Neuro-Localization
11 Chapter 11: Endocrine & Metabolic Crises
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Acute Adrenocortical Crisis (Addisonian Crisis) & Hypoadrenocorticism 11.3 Thyroid Storm, Feline Hyperthyroid Crises & Severe Hypoglycemia
12 Chapter 12: Reproductive & Musculoskeletal Emergencies
12.1 Reproductive Emergencies: Dystocia, Pyometra & Puerperal Hypocalcemia 12.2 Musculoskeletal Trauma: Open Fractures, Luxations, Splints & Compartment Syndrome 12.3 Rhabdomyolysis, Crush Injury & Polytrauma Damage Control Resuscitation
13 Chapter 13: Advanced Critical Care Monitoring, Vascular Access & The Rule of 20
13.1 Central Venous Catheterization, Arterial Lines & Intraosseous Access 13.2 Hemodynamic Monitoring: Invasive vs. Non-Invasive Blood Pressure, CVP & Cardiac Output 13.3 Kirby's Rule of 20: Comprehensive Daily Critical Patient Evaluation Checklist
8.4 Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia
Key Takeaways Explain This Topic AI
Acute Tumor Lysis Syndrome (TLS) is a metabolic catastrophe triggered by massive neoplastic cell breakdown following chemotherapy, presenting with the classic triad of severe hyperkalemia, severe hyperphosphatemia, and secondary hypocalcemia.
Non-traumatic hemoperitoneum secondary to ruptured splenic hemangiosarcoma presents with acute hemorrhagic shock; effusion PCV typically equals or exceeds peripheral PCV, and shed blood fails to clot in plain tubes due to defibrinogenation.
Emergency autotransfusion involves collecting and reinfusing cavity-shed blood through a 170–260 micron filter, serving as a life-saving bridge during massive hemorrhage when homologous blood is unavailable.
Humoral Hypercalcemia of Malignancy (HHM) is driven by tumor-derived PTHrP (most common in T-cell lymphoma and anal sac adenocarcinoma), causing ionized calcium toxicity, nephrogenic diabetes insipidus, and acute renal failure.
Emergency treatment of hypercalcemic crisis requires 0.9% NaCl saline diuresis (promoting calciuresis), followed by furosemide (only after rehydration), bisphosphonates (zoledronate/pamidronate), and delayed glucocorticoids pending definitive lymphoma diagnosis.
Last updated: August 2026
Oncologic Emergencies: Tumor Lysis Syndrome, Bleeding Masses & Hypercalcemia
Veterinary oncology patients frequently present to the emergency department with acute, life-threatening crises resulting directly from tumor burden, vascular invasion, paraneoplastic humoral syndromes, or cytotoxic therapy. Advanced veterinary nurses must rapidly recognize and stabilize three major oncologic emergencies: Acute Tumor Lysis Syndrome (TLS) , Acute Hemoperitoneum from Bleeding Masses , and Humoral Hypercalcemia of Malignancy (HHM) .
1. Acute Tumor Lysis Syndrome (TLS)
Tumor Lysis Syndrome (TLS) is an acute, life-threatening metabolic oncologic emergency caused by the rapid, massive lysis of neoplastic cells and the sudden dumping of intracellular contents into the systemic circulation. It classically develops 12 to 48 hours following induction chemotherapy (e.g., CHOP protocol for high-grade lymphoma, acute lymphoblastic leukemia, or large bulky solid tumors), but can occasionally occur spontaneously. [Tumor Lysis Syndrome Metabolic Quartet]
- Massive Lysis of Neoplastic Cells
- │
- ┌────────────────────────┼────────────────────────┐
- ▼ ▼ ▼
- [HYPERKALEMIA] [HYPERPHOSPHATEMIA] [PURINE RELEASE / URIC ACID]
- Intracellular K+ • Intracellular Phos • Nucleic acid catabolism
- floods circulation 4x higher in lymphs • Hyperuricemia & Urate Crystals
- Cardiotoxicity • Binds Ionized Calcium • Acute Renal Tubular Obstruction
- Lethal Bradycardia, • Calcium-Phosphate • Severe Metabolic Acidosis
- Spiked T-Waves, Precipitation (Ca x P >60)
- Vtach / Asystole │
- ▼
- [SECONDARY HYPOCALCEMIA]
- Tetany, Muscle Tremors
- Facial Rubbing, Seizures
- Prolonged QT Interval
- The Classic Electrolyte & Metabolic Alterations
Severe Hyperkalemia ( K + > 6.5 – 8.0 mEq/L K^+ > 6.5\text{–}8.0\text{ mEq/L} K + > 6.5 – 8.0 mEq/L ): Massive release of intracellular potassium. Produces severe cardiotoxicity: tall tented T-waves, widened QRS complexes, loss of P-waves, sine-wave rhythms, ventricular fibrillation, and asystolic cardiac arrest.
Severe Hyperphosphatemia ( P > 10 – 14 mg/dL P > 10\text{–}14\text{ mg/dL} P > 10 – 14 mg/dL ): Neoplastic lymphoblasts contain up to 4 times the intracellular phosphorus concentration of mature lymphocytes. Rapid phosphate release overwhelms renal excretory capacity.
Secondary Hypocalcemia ( i Ca 2 + < 0.8 mmol/L i\text{Ca}^{2+} < 0.8\text{ mmol/L} i Ca 2 + < 0.8 mmol/L ): Excess serum phosphate binds ionized calcium, forming insoluble calcium phosphate crystals that deposit in renal tubules and soft tissues when the Calcium × \times × Phosphorus product exceeds 60 – 70 mg 2 / dL 2 60\text{–}70\text{ mg}^2/\text{dL}^2 60 – 70 mg 2 / dL 2 . Causes neuromuscular hyperexcitability, tetanic muscle spasms, facial pruritus, and seizures.
Acute Kidney Injury (AKI) & Uremic Metabolic Acidosis: Precipitated by acute calcium phosphate nephrocalcinosis, hyperuricemic nephropathy, and renal tubular obstruction.
Emergency Management & Prevention of TLS
Aggressive IV Isotonic Crystalloid Diuresis: Administer 0.9% NaCl or balanced crystalloids at 2 – 3 × 2\text{–}3\times 2 – 3 × maintenance ( 6 – 9 mL/kg/hr 6\text{–}9\text{ mL/kg/hr} 6 – 9 mL/kg/hr ) starting 12–24 hours prior to chemotherapy and continuing for 48 hours post-treatment to maximize glomerular filtration and urine flow.
Cardioprotective Calcium Gluconate: If hyperkalemic ECG abnormalities are present, administer 10% Calcium Gluconate ( 0.5 – 1.0 mL/kg IV slow over 10–15 min 0.5\text{–}1.0\text{ mL/kg IV slow over 10–15 min} 0.5 – 1.0 mL/kg IV slow over 10–15 min ) with continuous ECG monitoring. (Stabilizes myocardial resting membrane potential without lowering serum potassium).
Potassium-Lowering Pharmacotherapy:
Regular Insulin ( 0.25 – 0.5 U/kg IV 0.25\text{–}0.5\text{ U/kg IV} 0.25 – 0.5 U/kg IV ) combined with 2.0 g Dextrose per Unit of insulin IV 2.0\text{ g Dextrose per Unit of insulin IV} 2.0 g Dextrose per Unit of insulin IV (shifts K + K^+ K + intracellularly via N a + / K + Na^+/K^+ N a + / K + -ATPase activation).
Nebulized Albuterol ( 0.05 mg/kg 0.05\text{ mg/kg} 0.05 mg/kg ) (beta-2 agonist shifting potassium intracellularly).
Phosphate Binders & Uric Acid Modulators: Aluminum hydroxide ( 30 – 50 mg/kg/day PO 30\text{–}50\text{ mg/kg/day PO} 30 – 50 mg/kg/day PO ) to bind enteric phosphorus; Allopurinol or Rasburicase to blunt uric acid crystalluria.
Loading diagram... Hemoperitoneum Triage & Oncologic Emergency Pathways
2. Hemoperitoneum from Bleeding Masses & Emergency Autotransfusion
Spontaneous, non-traumatic hemoperitoneum is a common presenting complaint in older large-breed dogs. The most common underlying etiology is a ruptured splenic tumor ( Splenic Hemangiosarcoma [HSA] accounting for ~2/3 of all splenic malignancies, versus benign splenic hematomas, followed by ruptured hepatic, retroperitoneal, or adrenal masses).
Triage & Point-of-Care Diagnostics
AFAST (Abdominal FAST) Ultrasound: Rapidly identifies anechoic fluid in the cysto-colic, spleno-renal, hepato-renal, and diaphragmatico-hepatic acoustic windows.
Diagnostic Abdominocentesis & PCV/TS Comparison:
Aspirate fluid using a 20G–22G needle or catheter.
The PCV Hallmark: In acute hemoperitoneum, the effusion PCV is typically equal to or higher than the peripheral blood PCV (often 10–20% higher due to splenic erythrocyte concentration).
The Clotting Test: True cavitary hemoperitoneum fails to clot in a plain glass/plastic tube (red-top) because peritoneal mesothelial cells rapidly defibrinogenate shed blood. If aspirated blood forms a firm clot, accidental iatrogenic vessel or organ puncture must be suspected.
Damage Control Resuscitation: Permissive Hypotension
In active, uncontrolled intra-abdominal hemorrhage, aggressive crystalloid boluses to achieve normal blood pressures dislodge newly formed, fragile platelet/fibrin plugs ("popping the clot") and dilute clotting factors.
Target Endpoints: Maintain permissive hypotension (Target MAP 50 – 60 mmHg 50\text{–}60\text{ mmHg} 50 – 60 mmHg or SBP 80 – 90 mmHg 80\text{–}90\text{ mmHg} 80 – 90 mmHg , palpably restored peripheral pulses, and mentation improvement) using small aliquots of balanced crystalloids ( 10 – 15 mL/kg 10\text{–}15\text{ mL/kg} 10 – 15 mL/kg ) or hypertonic saline ( 4 mL/kg 4\text{ mL/kg} 4 mL/kg ), while preparing for definitive surgical hemostasis.
Emergency Autotransfusion Protocols
When homologous donor blood products are unavailable and an exsanguinating patient faces imminent cardiac arrest, autotransfusion of cavity-shed blood can be lifesaving.
Technique: Peritoneal blood is aseptically aspirated into large syringes or a sterile suction canister. The blood is then re-infused into the patient's intravenous line through a standard 170–260 micron blood filter (or a 40-micron microaggregate filter).
Anticoagulant Requirement: Because shed intra-abdominal blood has already undergone mesothelial defibrinogenation, anticoagulant (ACD-A or citrate) is generally not required during collection, though some protocols add 1 mL ACD-A per 7–10 mL blood if rapid clotting is feared.
Contraindications & Complications:
Absolute Contraindication: Bacterial contamination (concurrent GI perforation, septic peritonitis) or gross urine/bile leakage.
Relative Caution in Neoplasia: Risk of re-infusing neoplastic cells (e.g., HSA cells). However, autotransfusion remains strictly indicated when the alternative is immediate fatal hemorrhagic shock.
3. Paraneoplastic Hypercalcemia (Humoral Hypercalcemia of Malignancy - HHM)
Hypercalcemia is the most common paraneoplastic syndrome in veterinary medicine, accounting for 60% to 70% of all hypercalcemic canine cases . Humoral Hypercalcemia of Malignancy (HHM) is mediated by tumor secretion of Parathyroid Hormone-related Protein (PTHrP) . [Humoral Hypercalcemia of Malignancy Pathophysiology]
- Neoplasm Secretes PTHrP (Lymphoma / AGASACA)
- │
- ┌────────────────────────┴────────────────────────┐
- ▼ ▼
- [BONE RESORPTION] [RENAL REABSORPTION]
- Activates Osteoclasts • Binds renal PTH receptors
- Massive mobilization of • Maximizes tubular Ca2+ reabsorption
- Calcium & Phosphorus into blood • Inhibits Aquaporin-2 & ADH (Nephrogenic DI)
- │ │
- └────────────────────────┬────────────────────────┘
- ▼
- [SEVERE IONIZED HYPERCALCEMIA]
- Polyuria / Polydipsia (PU/PD)
- Acute Renal Vasoconstriction & Ischemia
- Nephrocalcinosis -> Irreversible AKI
- Bradycardia, Shortened QT Interval
- Underlying Malignancies
Canine Lymphoma: Particularly T-cell lymphoma (~40% of hypercalcemic dogs).
Apocrine Gland Anal Sac Adenocarcinoma (AGASACA): Highly associated with severe PTHrP secretion (always perform a digital rectal examination on all sick dogs!).
Multiple Myeloma: Localized osteoclast-activating factors and bone resorption.
Carcinomas: Mammary, lung, and thyroid carcinomas.
Clinical Manifestations of Ionized Calcium Toxicity
Total serum calcium can be misleading due to fluctuations in albumin; ionized calcium ( i Ca 2 + i\text{Ca}^{2+} i Ca 2 + ; normal: 1.15 – 1.35 mmol/L 1.15\text{–}1.35\text{ mmol/L} 1.15 – 1.35 mmol/L ) reflects true physiological toxicity:
Renal Signs (Nephrogenic Diabetes Insipidus): Severe PU/PD. Hypercalcemia blocks antidiuretic hormone (ADH) signaling on aquaporin-2 channels in the renal collecting ducts, causing profound hyposthenuric polyuria.
Cardiovascular Signs: Bradycardia, shortened QT interval, ventricular arrhythmias, and systemic arterial hypertension.
Gastrointestinal & Neurological Signs: Anorexia, vomiting, severe constipation (decreased smooth muscle excitability), muscle weakness, tremors, and stupor.
Calcium × \times × Phosphorus Danger: When the total serum [ Ca ] × [ P ] [\text{Ca}] \times [\text{P}] [ Ca ] × [ P ] product exceeds 60 – 70 mg 2 / dL 2 60\text{–}70\text{ mg}^2/\text{dL}^2 60 – 70 mg 2 / dL 2 , metastatic mineral precipitation into renal basolateral membranes causes acute irreversible tubulointerstitial nephrocalcinosis and fatal anuric renal failure.
Emergency Multi-Tier Medical Management
Therapeutic Tier Drug & Intervention Protocol Mechanism of Action & Physiological Impact Critical Precautions & Clinical Rules
Tier 1: Saline Diuresis 0.9% NaCl IV at 2 – 3 × 2\text{–}3\times 2 – 3 × maintenance ( 60 – 90 mL/kg/day 60\text{–}90\text{ mL/kg/day} 60 – 90 mL/kg/day ). High sodium concentration competes with calcium for tubular reabsorption in the thick ascending Loop of Henle, forcing urinary calcium excretion ( calciuresis ). The fluid of choice; avoid calcium-containing fluids (LRS).
Tier 2: Loop Diuretics Furosemide: 1.0 – 2.0 mg/kg IV q8–12h 1.0\text{–}2.0\text{ mg/kg IV q8–12h} 1.0 – 2.0 mg/kg IV q8–12h . Inhibits N a + / K + / 2 C l − Na^+/K^+/2Cl^- N a + / K + /2 C l − cotransporter in the loop of Henle, impairing calcium reabsorption and enhancing calciuresis. STRICTLY CONTRAINDICATED in dehydrated patients! Administer only AFTER full vascular volume expansion.
Tier 3: Bisphosphonates Zoledronate ( 0.1 – 0.25 mg/kg IV 0.1\text{–}0.25\text{ mg/kg IV} 0.1 – 0.25 mg/kg IV in saline over 15 min) or Pamidronate ( 1.0 – 1.5 mg/kg IV 1.0\text{–}1.5\text{ mg/kg IV} 1.0 – 1.5 mg/kg IV over 2–4 hours) . Potent inhibition of osteoclast-mediated bone resorption and induction of osteoclast apoptosis; effects last weeks. Max effect achieved in 24–48 hours; monitor renal parameters.
Tier 4: Glucocorticoids Prednisone ( 1.0 – 2.0 mg/kg/day PO 1.0\text{–}2.0\text{ mg/kg/day PO} 1.0 – 2.0 mg/kg/day PO ) or Dexamethasone SP ( 0.1 – 0.2 mg/kg IV 0.1\text{–}0.2\text{ mg/kg IV} 0.1 – 0.2 mg/kg IV ) . Promotes urinary calciuresis, decreases intestinal calcium absorption, and induces cytotoxic lympholysis. CRITICAL ONCOLOGY RULE: NEVER administer glucocorticoids prior to obtaining a definitive tissue biopsy/cytology of suspected lymphoma! Pre-treatment destroys neoplastic tissue architecture and induces multidrug resistance (P-glycoprotein upregulation).
Tier 5: Calcitonin Salmon Calcitonin ( 4 – 8 IU/kg SC q8–12h 4\text{–}8\text{ IU/kg SC q8–12h} 4 – 8 IU/kg SC q8–12h ) . Rapidly inhibits osteoclast activity and decreases renal calcium reabsorption. Provides rapid transient lowering of calcium within hours; limited by tachyphylaxis/receptor down-regulation in 2–3 days.